Pharmacokinetic crossover trials on GelShield Extended-Release Metformin gut tolerability, topical Diclofenac patch RCTs for targeted joint relief without GI bleeding, and Phase 3 biologic clearance trials in psoriasis and autoimmune disease. Explore 546 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
In conclusion, the pooled analysis showed no statistically significant difference between EN-DCR with and without silicone intubation. However, the certainty of evidence ranged from low to very low, and the true comparative effect remains uncertain.
Moderate certainty evidence suggests short term pain reduction with extracorporeal shockwave therapy and improved short term flexion with manipulation under anaesthesia, with or without intra-articular steroid injections.
The findings of this review showed that the use of BCD for wound treatment appeared to bolster the healing process and offer pain relief. Further extensive studies are required to confirm these preliminary observations and guide their clinical application.
In patients undergoing TLH, a combination of dexamethasone, PCM, and ketorolac reduced 24-h opioid use, improved pain scores, and minimized immediate postoperative nausea and vomiting.
The two devices did not exhibit significant differences in terms of pain or bleeding complications when used for prostate biopsy.
J Orthop Sports Phys Ther 2026;56(11):710-723. doi:10.2519/jospt.2026.14210 .
Finafloxacin otic suspension was statistically superior to vehicle in clinical cures, pathogen eradication, and median time to ear pain resolution.
A brief educational video effectively improved back pain beliefs but did not alter lifting behaviour or spinal motion.
There was a tendency towards reduced vancomycin resistance and ARG reduction after rifamycin exposure. Registration: NCT04082780 www.clinicaltrials.gov.
J Orthop Sports Phys Ther 2026;56(11):735-744. doi:10.2519/jospt.2026.14073 .
Walnut consumption may be associated with small reductions in CRP and IL-6 levels, without significant effects on TNF-α or adipokine concentrations. However, these effects are modest, and their clinical relevance remains uncertain.
A brief psychoeducational intervention significantly reduced psychological stress in dermatology outpatients.
Ocrelizumab treatment is associated with declining myo-inositol levels measured by MRS in both RMS and PPMS.
Although male patients had earlier clinical responses to bimekizumab treatment, female patients demonstrated longer-term improvements in composite and patient-reported outcomes.
This prematurely ended study failed to confirm REX-001's efficacy for ulcer healing.
Patients with poorer disease-specific QoL, but not necessarily those with more severe symptoms or higher scores for anxiety and depression, are particularly likely to incur higher annual costs.
Treatment with abatacept and MTX resulted in significantly greater reduction of biomarkers relevant to RA, and high baseline IL-10 levels predicted better treatment response with abatacept and MTX versus placebo and MTX across...
The purpose of this paper is to evaluate patient characteristics and treatment outcomes in patients with nonradiographic axial spondyloarthritis (nr-axSpA) eligible for a clinical trial based on the 2009 established Assessment...
Increasing pulse duration broadened relative muscle recruitment and enhanced distal muscle activation, but posture remained the dominant determinant of overall response magnitude.
Mepolizumab improved exacerbation-related outcomes in patients with COPD and type 2 inflammation, characterized by both consistently and intermittently elevated BEC.
This subanalysis of the SELECT-EARLY Japanese population corroborates findings from the global study population on the long-term clinical real-world benefits and safety of upadacitinib.
ADA induction had no apparent impact on safety.
Switching from Ref-GLM to BAT2506 showed comparable efficacy, safety, immunogenicity, and PK profiles to continued treatment with BAT2506 or Ref-GLM.
Delayed gastric emptying appears to play little direct role in appetite suppression induced by liraglutide.
Three of the four participants had undergone SOT.
Picankibart provided effective skin clearance in Chinese participants by week 16.
Tirzepatide 15 mg and CagriSema achieve the greatest weight reduction, including ≥ 20% body weight loss.
Mediation analysis supports a bile-acid-mediated suppression of inflammatory pathways linking microbial changes to antidepressant effects.
Nipocalimab + SOC demonstrated early and sustained fatigue and HRQoL improvements over 24 weeks.
Baseline serum proteomics captures core disease characteristics of MG and predicts short-term clinical response in a treatment-specific manner.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.
